ProfileGDS5678 / 1417299_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 42% 42% 42% 39% 40% 49% 40% 42% 41% 41% 42% 42% 46% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.0016542
GSM967853U87-EV human glioblastoma xenograft - Control 22.9690342
GSM967854U87-EV human glioblastoma xenograft - Control 32.9685442
GSM967855U87-EV human glioblastoma xenograft - Control 42.8311839
GSM967856U87-EV human glioblastoma xenograft - Control 52.8809440
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2637849
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.9947140
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.9546142
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.921841
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.9239341
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.9668142
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.9338842
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.0815246
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.9657542